FindMyKOL

David Cotter, MD, PhD

Basic profile

University of Nevada

ORCID↗NPI↗
✓ Full record
RegionLas Vegas, NV · WestSpecialtyDermatologyFocusDermatology
Active KOLEmergingFindMyKOL type: NationalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

David Cotter is a Dermatology physician affiliated with University of Nevada. OpenAlex indexes 50 publications with 1,415 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
50publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,415citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
49companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

653 N Town Center Dr Ste 414
Las Vegas, NV 891440518

Telephone

702-456-3120

Provider last certified this registry record 24 Aug 2023.

View the NPPES registry record

Industry payments

49 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

  • The Therapeutic Potential of Glucagon-Like Peptide-1 Receptor Agonists in Psoriasis and Hidradenitis Suppurativa.

    PubMed

    2026
  • A Transient "Blueberry Muffin" Rash in a Neonate with Acute Myeloid Leukemia: A Case Report and Review of the Literature.

    PubMed

    2026
  • Clinical Management of Dupilumab-related Conjunctivitis, Erythema, and Arthralgia in Atopic Dermatitis: Evidence From Two Cases Treated with Nemolizumab.

    PubMed

    2026
  • Pumping Up Dermatologic Drug Reformulation: A Review of How Proton Pump Inhibitors May Revolutionize Scleroderma Treatment.

    PubMed

    2026
All 42 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”